Christian Rolfo: Putalyo Calvo on overcoming PD-1/PD-L1 immunotherapy limitations
Christian Rolfo, Division Director of Medical Oncology at The James Comprehensive Cancer Center, shared a post on X:
“Excellent PhD thesis dissertation by Dr. Ander Putalyo Calvo at the University of Navarra – ‘Inhibitor of Id1: novel strategies to overcome PD-1/PD-L1 immunotherapy limitations in KRAS-mut lung Adenocarcinoma’.
An honor to be co-director with Gil Bazo. Congratulations! Great job!”
More posts featuring Christian Rolfo.
Christian Rolfo MD, PhD, MBA, Dr.hc. is the Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at The James Comprehensive Cancer Center, Ohio State University.
He also serves as a Professor of Internal Medicine-Oncology at Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute. He has authored over 350 scientific articles & contributions to book chapters.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023